In silico Screening of Potential Drug Candidate against Chain a of Coronavirus Binding Protein from Major Nigella Bioactive Compounds
Md. Bokhtiar Rahman, Simo, A.B.M Abdullah, Saba Tabassum, Toukir
Asian Journal of Advanced Research and Reports · pp. 224–238 · Published 25 Jun 2024
10.9734/ajarr/2024/v18i7697Abstract
Background: More hazardous varieties of severe acute respiratory syndrome-related coronavirus have created major health hazards around the globe since 2019. There is no hundred percent effective drug has been developed against this virus. Bioactive compounds from plants are used as drugs or the main source of raw material for drugs against various diseases. Aims: To screen the potential drug candidate against coronavirus from major Nigella bioactive compounds. Methods and Materials: In the first step of our computational biology-dependent study, we selected six major Nigella compounds, four major drugs used in COVID-19 treatment, and a binding protein of coronavirus. In the second step, we processed the ligands and peptides and performed a docking to test the binding affinity. In the final step, we selected a compound with the highest binding affinity and performed molecular simulation, ADME/T, bioactivity, and QSAR analysis to characterize this molecule as a drug candidate. Results: Four different antiviral agents that had been used in the treatment of COVID-19 patients showed less binding affinity in molecular docking compared with six bioactive compounds of Nigella. Nigellamine C, Nigeglanine, nigellamine D, nigellicine, nigellidine, and nigellone showed binding affinity of -7.9, -7.5, -7.3, -6.5, -7, and -6.7 kcal/mol, respectively whereas ribavirin, favipiravir, remdesivir, and nirmatrelvir showed -5.1, -4.8, -6.2, and -5.9 kcal/mol, accordingly to chain A of subunit 1 (S1) of the spike protein of coronavirus. Nigellamine C showed the highest binding affinity and suitable ADME/T properties with negligible toxic properties and good drug-likeness properties. Conclusion: Nigellamine C may be a potent candidate for inhalation and/or oral drug development based on QSAR analysis and ADME/T analysis among all Nigella compounds.
References (31)
- 1 PROCHECK: a program to check the stereochemical quality of protein structures [DOI]
- 2 MEGA11: Molecular Evolutionary Genetics Analysis Version 11 [DOI]
- 3 SWISS-MODEL: homology modelling of protein structures and complexes [DOI]
- 4 Open Babel: An open chemical toolbox [DOI]
- 5 Protein Identification and Analysis Tools on the ExPASy Server [DOI]
- 6 Molecular Properties That Influence the Oral Bioavailability of Drug Candidates [DOI]
- 7 ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins [DOI]
- 8 pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures [DOI]
- 9 Small-Molecule Library Screening by Docking with PyRx [DOI]
- 10 New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays [DOI]
- 11 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [DOI]
- 12 ProTox-II: a webserver for the prediction of toxicity of chemicals [DOI]
- 13 A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases [DOI]
- 14 Recognition of errors in three‐dimensional structures of proteins [DOI]
- 15 Prediction of Drug Absorption Using Multivariate Statistics [DOI]
- 16 NPS@: Network Protein Sequence Analysis [DOI]
- 17 The PSIPRED Protein Analysis Workbench: 20 years on [DOI]
- 18 A Bioavailability Score [DOI]
- 19 Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods [DOI]
- 20 Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases [DOI]
- 21 Studies on the antimicrobial activity of Nigella sativa seed (black cumin) [DOI]
- 22 Nature's medicinal bounty: don't throw it away.
- 23 The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review.
- 24 Clinical trials for COVID-19 should include sex as a variable [DOI]
- 25 SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Ipomoea mauritiana Jacq
- 26 SARS-CoV-2: Receptor and Co-receptor Tropism Probability [DOI]
- 27 Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity [DOI]
- 28 The Design of Leadlike Combinatorial Libraries [DOI]
- 29 myPresto/omegagene: a GPU-accelerated molecular dynamics simulator tailored for enhanced conformational sampling methods with a non-Ewald electrostatic scheme [DOI]
- 30 Underappreciated Chemical Interactions in Protein–Ligand Complexes [DOI]
- 31 STopTox: An In-Silico Alternative to Animal Testing for Acute Systemic and TOPical TOXicity [DOI]
Cited by 2
Santosh Prasad Chaudhary Kurmi, Dipanjan Karati · Brain Disorders · 2025
Showing 1 of 2 known citations — external sources report more than can currently be individually listed.
Related research
- Antibacterial Activity of Bidens pilosa Extracts on Escherichia coli O157: H7 Isolated from Apparently Healthy Individuals — shares topic coverage
- Antimicrobial Activity, Phytochemical Screening and Nutrient Analysis of Tetrapleura tetraptera and Piper guineense — shares topic coverage
- Phytochemical and Nutraceutical Potentials of Beach Bean (Canavalia rosea SW.) DC Grown in Anyigba, Kogi State, Nigeria — shares topic coverage
- Phytochemical Screening, In vitro Antioxidant Capacity and Nephro-protective Effects of Combined Extract of Psidium guajava and Carica papaya Leaves in Rats Intoxicated with Cadmium — shares topic coverage
- Therapeutic Potential of Phytochemicals in Autoimmune Diseases: A Systematic Review — shares topic coverage
Article metrics
Real usage data collected on this platform.
42
Page views
0
PDF downloads
5
Outbound clicks
2
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.